Orlando, FL, United States of America

Masanobu Komatsu

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Vascular Biosciences, Sanford-Burnham Medical Research Institute, Sanford Burnham Prebys Medical Discovery Institute. Active years: 2013-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masanobu Komatsu. Retrieved from https://idiyas.com/inventor/masanobu-komatsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Orlando, FL (US) (2013 - 2015)
  • La Jolla, CA (US) (2018 - 2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Inventor Masanobu Komatsu: Advancements in Targeted Therapies**

Introduction

Masanobu Komatsu is a notable inventor based in Orlando, FL, who has made significant contributions to the field of targeted therapies. With a total of four patents to his name, his innovations focus on developing compositions and methods that enhance therapeutic outcomes for various diseases.

Latest Patents

Masanobu Komatsu's latest patents include breakthrough technologies. One of his patents is titled "Compositions containing a pharmacophore with selectivity to diseased tissue and methods of making same." This innovation focuses on compositions and methods that deliver targeted therapies for pulmonary arterial hypertension, sepsis, cancer, and cachexia. The inventions are based on peptide pharmacophores that selectively bind to diseased tissues, enabling targeted therapies to produce beneficial therapeutic results. Another significant patent, "Car peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders," discloses compositions and methods useful for delivering targeted therapies specifically for pulmonary diseases, fibrotic disorders, and cancer. These peptide sequences help home in on diseased tissue, facilitating the application of therapeutic and detectable agents.

Career Highlights

Throughout his career, Masanobu Komatsu has collaborated with reputable organizations such as Vascular Biosciences and Sanford-Burnham Medical Research Institute. His work at these institutions has allowed him to contribute significantly to the advancement of biomedical research and therapies.

Collaborations

Masanobu has worked alongside renowned colleagues including David M Mann and Erkki I Ruoslahti. These collaborations have been integral in fostering innovative solutions and advancing research in targeted therapies, showcasing the collaborative nature of scientific discovery.

Conclusion

Masanobu Komatsu has established himself as a pivotal figure in the realm of targeted therapies through his innovative patents and collaborations. His dedication to developing compositions that address complex diseases continues to inspire advancements in medical treatments, showcasing the profound impact that inventors can have on healthcare and patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…